BioSpace News Archive

Biotech Bay

Adamas Announces U.S. Commercial Launch of GOCOVRI the First and Only FDA-Approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

Today’s launch marks the deployment of Adamas’ dedicated team of 59 neurology field sales professionals, who are focused on educating the Parkinson’s disease community about the benefit/safety profile of GOCOVRI.

January 9, 2018
·
8 min read
Business

Battelle Tapped to Help U.S. Government Prevent the Intentional or Accidental Creation of Synthetic Biological Threats

Battelle has been awarded a contract by the Intelligence Advanced Research Projects Activity (IARPA) to develop threat assessment software to help prevent the creation of dangerous organisms.

January 9, 2018
·
5 min read
Genetown

GC3 Announces Call for Applications for 2018 Startup Technology Showcase

Ten startups will be selected to present their technologies and begin discussions with large companies that could lead to joint development agreements, licensing, investment, and other business opportunities.

January 9, 2018
·
4 min read
Viemed Announces Further Details of Plan of Arrangement and Engagement of IR Firm

As a result of the foregoing adjustments, Viemed has 878,298 Viemed Options outstanding, with exercise prices ranging from $1.44 to $8.44 and expiry dates ranging from February 9, 2018 to July 28, 2025.

January 9, 2018
·
9 min read
Drug Development

Novartis Advances Head-to-Head Superiority Trials of Cosentyx Versus Humira And Proposed Biosimilar Adalimumab

SURPASS and EXCEED are part of a larger rheumatology program for Cosentyx.

January 9, 2018
·
13 min read
Pharm Country

Tauriga Sciences on Track to Become Completely Free of Convertible Debt

As of today’s date, the Company reports that less than $225,000 of Face Value convertible debt remains (in aggregate).

January 9, 2018
·
3 min read
NIH Awards Longeveron Cutting-Edge Research Grant to Fight ‘Metabolic Syndrome’ of Obesity, High Blood Pressure, Unhealthy Cholesterol and More through Regenerative Medicine

The NIA recognized this, and recently awarded a prestigious research grant to Longeveron, a regenerative medicine therapy company based in Miami, Florida.

January 9, 2018
·
2 min read
Drug Development

FDA Calls Bay Area Global Blood Therapeutics’ Sickle Cell Drug a Breakthrough

The BTD decision for voxelotor was based on clinical data submitted from a trio of studies.

January 9, 2018
·
6 min read
Business

Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results

Full year 2017 estimated sales are expected to be approximately $635.4 million, an increase of 12.7% over the prior year.

January 9, 2018
·
8 min read
Business

CardioFocus Announces Expanded Partnership With Japan Lifeline

The expanded partnership solidifies the commercial strategy for bringing the HeartLight Endoscopic Ablation System to the Japanese market.

January 9, 2018
·
3 min read